Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-10-29 20:56:30 ET
Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT...
Read the full article on Seeking Alpha
For further details see:
Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript
Emergent Biosolutions Inc.
NASDAQ: EBS
EBS Trading
1.94% G/L:
$8.41 Last:
281,980 Volume:
$8.47 Open:
EBS Latest News
March 03, 2026 08:00:00 am
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
February 26, 2026 04:05:00 pm
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness
February 26, 2026 04:01:00 pm
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
EBS Stock Data
$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg
